Videos

Aortic Regurgitation in 2022 - Undertreatment, Timing of Intervention, TAVR and Future Evidence Needs

James M. McCabe, Vinod H. Thourani, Nadira Hamid, Ravi Ramana and Mark J. Russo discuss JenaValve’s Trilogy System as a solution for severe AR patients at the “Aortic Regurgitation in 2022 – Undertreatment, Timing of Intervention, TAVR and Future Evidence Needs” symposium.

Latest News

View All
Press
New, Late-Breaking Results from the ALIGN-AR Trial Published in The Lancet and Presented at PCR London Valves
November 24, 2025
New, Late-Breaking Results from the ALIGN-AR Trial Published in The Lancet and Presented at PCR London Valves
Read More
Press
JenaValve‘s Trilogy™ System Featured in Live Procedure at TCT 2025
November 10, 2025
JenaValve‘s Trilogy™ System Featured in Live Procedure at TCT 2025
Read More
Press
JenaValve Announced ESC Guidelines Recognize TAVI as Class IIb Recommendation for Aortic Regurgitation
September 10, 2025
JenaValve Announced ESC Guidelines Recognize TAVI as Class IIb Recommendation for Aortic Regurgitation
Read More
Close Download
Close Download
The JenaValve TrilogyTM Heart Valve System Billing Guide contains appropriate coding (e.g. CPT, ICD-10, and HCPCS), coverage, and payment for procedures performed with the JenaValve TrilogyTM Heart Valve System. For additional information, please contact us at reimbursement.usa@jenavalve.com.